ArticleContemporary clinical trials2020

Rationale and design of the granulocyte-macrophage colony stimulating factor in peripheral arterial disease (GPAD-3) study.

Anurag Mehta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.